NASDAQ: NVNOEnvveno Medical Corp Stock Ownership - Who owns Envveno Medical?
Insider buying vs selling
Have Envveno Medical Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Francis Duhay | Director | 2024-12-31 | 81,433 | $3.07 | $250.00kBuy |
| Robert Gray | Director | 2024-12-31 | 3,500 | $2.94 | $10.29kBuy |
| Sanjay Shrivastava | Director | 2024-12-24 | 5,400 | $2.90 | $15.66kBuy |
| Robert Andrew Berman | Chief Executive Officer | 2024-12-19 | 12,000 | $2.55 | $30.60kBuy |
| Matthew Jenusaitis | Director | 2024-12-19 | 9,620 | $2.53 | $24.34kBuy |
NVNO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NVNO insiders and whales buy or sell their stock.
NVNO Shareholders
What type of owners hold Envveno Medical Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Yury Zhivilo | 25.54% | 4,478,581 | $10.84M | Insider |
| Browston Trading Ltd | 25.34% | 4,443,569 | $10.75M | Insider |
| Holding Sa Biodyne | 8.01% | 1,405,433 | $3.40M | Insider |
| Kingdon Capital Management LLC | 4.90% | 859,261 | $2.08M | Institution |
| Nantahala Capital Management LLC | 3.40% | 596,917 | $1.44M | Institution |
| Vanguard Group Inc | 3.36% | 589,141 | $1.43M | Institution |
| Benedict Broennimann | 2.50% | 437,778 | $1.06M | Insider |
| Altium Capital Management LLC | 1.77% | 310,000 | $750.20k | Institution |
| Oconnor A Distinct Business Unit Of Ubs Asset Management Americas LLC | 1.69% | 296,031 | $716.40k | Institution |
| Jpmorgan Chase Co | 1.54% | 270,041 | $653.50k | Institution |
NVNO vs Medical Device Stocks
Envveno Medical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.